摘要
目的：探讨β刺激纤维细胞治疗对心脏衰竭患者的治疗效果。方法：对100例不同程度心脏衰竭患者进行干预治疗，给予不同量的β刺激纤维细胞，观察患者在不同程度干预治疗下的效果，在β刺激纤维细胞干预治疗第1~2天选择2种不同的β刺激量、β刺激机，先后进行β刺激纤维细胞干预治疗。结果：β刺激纤维细胞干预治疗结束时，82例心脏衰竭得到明显抑制，18例无明显改善，无恶化病例，持续性β刺激，间歇性β刺激、随弃式β刺激、小型β刺激机、大型β刺激机依从性良好，分别为19、34、25、22、29人次，持续性β刺激治疗评分为82，间歇性β刺激治疗评分为85，随弃式β刺激治疗评分为89。结论：β刺激纤维细胞治疗对心脏衰竭患者具有明显的心脏衰竭缓解作用，不同刺激量对于心脏病的缓解作用大小不一，间歇性β刺激治疗略好于持续性β刺激治疗和随弃式β刺激。
Objective：Investigateβstimulates fibroblasts therapy outcomes for heart failure patient. Methods：100 cases of heart failure patients with varying degrees are researched, different amounts ofβstimulates fibroblasts is given, the effect is observed for patients with varying degrees, the intervention under the β stimulates fibroblasts intervention 1 to 2 days is changed to select two different amount of stimulationβ,βstimulation machine, has conductedβstimulates fibroblasts inter-vention. Results：at the end of treatment, 82 cases of heart failure is significantly inhibited, 18 cases without significant im-provement, no deterioration cases, persistent βstimulation, intermittent stimulation of β,βstimulate disposable, small βstimulation machine, largeβstimulation machine compliance are selected, each team number is 19, 34, 25, 22, 29. Persis-tentβstimulation treatment score is 82, intermittentβstimulation treatment score is 85, with disposableβstimulation treat-ment score is 89. Conclusion：βstimulates fibroblasts therapy has effect for heart failure patients with significant heart fail-ure relief, the amount of stimulation and different stimuli is different with machine sizes for ease effects of heart disease, in-termittentβstimulation treatment is slightly better than continuingβstimulation therapy and disposableβstimulation.
出处
《科技通报》
北大核心
2014年第10期40-42,共3页
Bulletin of Science and Technology
作者简介
李克梅（1965-）女，宁夏固原人，本科，讲师，研究方向：内科护理。
